Endoscopic Procedures of Children in the Normalization Process of Covid-19 Pandemic

Evaluation of Children Who Were Underwent Endoscopic Procedures in the Normalization Process of Covid-19 Pandemic

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04598256

Enrollment

Registered

2020-10-22

Start date

2020-06-01

Completion date

2020-08-31

Last updated

2020-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19

Keywords

endoscopy, colonoscopy, children, Covid -19 pandemic

Brief summary

Endoscopic methods are frequently used in the diagnosis of gastrointestinal system pathologies in children.

Detailed description

Endoscopic methods are frequently used in the diagnosis of gastrointestinal system pathologies in children. In the investigators' center, which is a pandemic hospital, only emergency endoscopic procedures were performed during the pandemic period, while emergency and elective endoscopic procedures are performed in accordance with the recommendations of the Ministry of Health during the normalization process. Staff and patients in endoscopy units are at risk for COVID-19 infection by inhalation of airborne droplets, conjunctival contact, and potential fecal-oral contamination. In order to reduce the risk of contamination, according to the recommendations of the European Gastrointestinal Endoscopy Association (ESGE); proper cleaning of endoscopic devices, non-reuse of disposable devices, cleaning the endoscopy hall with a disinfectant solution, use of gowns FFP2 / 3 masks and jewelry during the procedure, handwashing with soap and hand disinfection is recommended before and after each procedure. In addition, it is recommended that patients who have undergone endoscopic procedures should be followed up or communicated on days 7 and 14 in terms of the development of COVID-19 infection. It is recommended that patients should be questioned in terms of COVID-19 infection before endoscopy, but rapid antigen testing and serology are not routinely recommended. Molecular diagnosis (PCR, amplification) tests are recommended for patients at risk for COVID-19 infection.

Interventions

PROCEDUREEndoscopic procedure

Esophagogastroscopy and colonoscopy

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

1 Years to 18 Years

Healthy volunteers

Inclusion criteria

* Children between the ages of 1-18 who will undergo endoscopic procedures * Patients who can be questioned about COVID-19 infection before and on the 7th and 14th days after the procedure * Patients who volunteered to study

Exclusion criteria

* Under 1 year and over 18 years of age * Patients who could not be questioned about COVID-19 infection before the procedure and on the 7th and 14th days after the procedure * Patients who not volunteered to study

Design outcomes

Primary

Measure	Time frame	Description
The number of participiants who was infected with Covid-19. normalization process of Covid-19 pandemic	14 days	The number of participiants who had Covid-19 infection after the endoscopic procedures.
The time of seen covid 19 infection after the endoscopic procedures in participiants.	14 days	The developed time of covid 19 infection after the endoscopic procedures in participiants.
The characteristics of patients with Covid-19 infection.	14 days	The characteristics of patients with Covid-19 infection after the endoscopic procedures in participiants.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026